Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - X4 Pharmaceuticals, Inc | asns-ex322_469.htm |
| EX-32.1 - EX-32.1 - X4 Pharmaceuticals, Inc | asns-ex321_470.htm |
| EX-31.2 - EX-31.2 - X4 Pharmaceuticals, Inc | asns-ex312_467.htm |
| EX-31.1 - EX-31.1 - X4 Pharmaceuticals, Inc | asns-ex311_468.htm |
| EX-10.37 - EX-10.37 - X4 Pharmaceuticals, Inc | asns-ex1037_392.htm |
| 10-K - 10-K - X4 Pharmaceuticals, Inc | asns-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (333-221622) of Arsanis, Inc. of our report dated March 9, 2018 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, MA
March 9, 2018